{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:38:21Z","timestamp":1788781101939,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Key research and development projects of the Ministry of Science and Technology","award":["2024YFC2510500"],"award-info":[{"award-number":["2024YFC2510500"]}]},{"name":"the National Natural Science Foundation Project","award":["82470141, 82270142, 82300239"],"award-info":[{"award-number":["82470141, 82270142, 82300239"]}]},{"name":"the Tianjin Municipal Natural Science Foundation","award":["24ZGSSSS00050"],"award-info":[{"award-number":["24ZGSSSS00050"]}]},{"name":"the Tianjin Science and Technology Planning Project","award":["24ZXGZSY00090"],"award-info":[{"award-number":["24ZXGZSY00090"]}]},{"name":"Tianjin Municipal Health Commission Project","award":["TJWJ2023XK003"],"award-info":[{"award-number":["TJWJ2023XK003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02060-3","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T08:24:37Z","timestamp":1770452677000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ruxolitinib reduces macrophage pyroptosis in aplastic anaemia"],"prefix":"10.1007","volume":"26","author":[{"given":"Xintong","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congwei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorui","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"issue":"17","key":"2060_CR1","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMra1413485","volume":"379","author":"NS Young","year":"2018","unstructured":"Young NS. Aplastic Anemia. N Engl J Med. 2018;379(17):1643\u201356.","journal-title":"N Engl J Med"},{"issue":"12","key":"2060_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11864-017-0511-z","volume":"18","author":"SA Peslak","year":"2017","unstructured":"Peslak SA, Olson T, Babushok DV. Diagnosis and Treatment of Aplastic Anemia. Curr Treat Options Oncol. 2017;18(12):70.","journal-title":"Curr Treat Options Oncol"},{"issue":"25","key":"2060_CR3","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1182\/blood-2014-01-549527","volume":"124","author":"FC Lin","year":"2014","unstructured":"Lin FC, Karwan M, Saleh B, et al. IFN-\u03b3 causes aplastic anemia by altering hematopoietic stem\/progenitor cell composition and disrupting lineage differentiation. Blood. 2014;124(25):3699\u2013708.","journal-title":"Blood"},{"issue":"1","key":"2060_CR4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/16078454.2019.1642548","volume":"24","author":"L Wang","year":"2019","unstructured":"Wang L, Liu H. Pathogenesis of aplastic anemia. Hematol. 2019;24(1):559\u201366.","journal-title":"Hematol"},{"issue":"2","key":"2060_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s12185-010-0761-z","volume":"93","author":"S Zonghong","year":"2011","unstructured":"Zonghong S, Meifeng T, Huaquan W, et al. Circulating myeloid dendritic cells are increased in individuals with severe aplastic anemia. Int J Hematol. 2011;93(2):156\u201362.","journal-title":"Int J Hematol"},{"issue":"3","key":"2060_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/cei.12605","volume":"180","author":"Y Zeng","year":"2015","unstructured":"Zeng Y, Katsanis E. The complex pathophysiology of acquired aplastic anaemia. Clin Exp Immunol. 2015;180(3):361\u201370.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"2060_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3109\/08820139.2014.888448","volume":"43","author":"C Liu","year":"2014","unstructured":"Liu C, Li Z, Sheng W, et al. Abnormalities of quantities and functions of natural killer cells in severe aplastic anemia. Immunol Invest. 2014;43(5):491\u2013503.","journal-title":"Immunol Invest"},{"issue":"7","key":"2060_CR8","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1046\/j.1440-1827.1999.00913.x","volume":"49","author":"Y Sadahira","year":"1999","unstructured":"Sadahira Y, Wada H, Manabe T, et al. Immunohistochemical assessment of human bone marrow macrophages in hematologic disorders. Pathol Int. 1999;49(7):626\u201332.","journal-title":"Pathol Int"},{"issue":"16","key":"2060_CR9","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1182\/blood-2014-04-568451","volume":"124","author":"AM de Bruin","year":"2014","unstructured":"de Bruin AM, Voermans C, Nolte MA. Impact of interferon-\u03b3 on hematopoiesis. Blood. 2014;124(16):2479\u201386.","journal-title":"Blood"},{"issue":"10","key":"2060_CR10","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1182\/blood-2005-10-4201","volume":"107","author":"EE Solomou","year":"2006","unstructured":"Solomou EE, Keyvanfar K, Young NS. T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia. Blood. 2006;107(10):3983\u201391.","journal-title":"Blood"},{"issue":"4","key":"2060_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","volume":"42","author":"J Shi","year":"2017","unstructured":"Shi J, Gao W, Shao F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci. 2017;42(4):245\u201354.","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"2060_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.yexcr.2018.01.035","volume":"364","author":"M Dai","year":"2018","unstructured":"Dai M, Pan P, Li H, et al. The antimicrobial cathelicidin peptide hlF(1\u201311) attenuates alveolar macrophage pyroptosis induced by Acinetobacter baumannii in vivo. Exp Cell Res. 2018;364(1):95\u2013103.","journal-title":"Exp Cell Res"},{"issue":"7521","key":"2060_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature13683","volume":"514","author":"J Shi","year":"2014","unstructured":"Shi J, Zhao Y, Wang Y, et al. Inflammatory caspases are innate immune receptors for intracellular LPS. Nat. 2014;514(7521):187\u201392.","journal-title":"Nat"},{"key":"2060_CR14","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1182\/blood-2021-152471","volume":"138","author":"TZ Rong Fu","year":"2021","unstructured":"Rong Fu TZ, Deng L, Zhao Y, Zhao X, Liu C, Shao Z. The Role of TLR4 Inducing macrophage pyroptosis in the pathogenesis of severe aplastic anemia. Blood. 2021;138:1114.","journal-title":"Blood"},{"issue":"1","key":"2060_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1182\/blood.2022015898","volume":"141","author":"EM Groarke","year":"2023","unstructured":"Groarke EM, Feng X, Aggarwal N, et al. Efficacy of JAK1\/2 inhibition in murine immune bone marrow failure. Blood. 2023;141(1):72\u201389.","journal-title":"Blood"},{"issue":"4","key":"2060_CR16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s10875-024-01687-9","volume":"44","author":"JY Koh","year":"2024","unstructured":"Koh JY, Kim DR, Son S, et al. Ruxolitinib improves immune-dysregulation features but not epigenetic abnormality in a patient with STAT1 GOF. J Clin Immunol. 2024;44(4):84.","journal-title":"J Clin Immunol"},{"issue":"12","key":"2060_CR17","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.exphem.2004.08.006","volume":"32","author":"ML Bloom","year":"2004","unstructured":"Bloom ML, Wolk AG, Simon-Stoos KL, et al. A mouse model of lymphocyte infusion-induced bone marrow failure. Exp Hematol. 2004;32(12):1163\u201372.","journal-title":"Exp Hematol"},{"issue":"10","key":"2060_CR18","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3324\/haematol.2017.163675","volume":"102","author":"X Feng","year":"2017","unstructured":"Feng X, Lin Z, Sun W, et al. Rapamycin is highly effective in murine models of immune-mediated bone marrow failure. Haematol. 2017;102(10):1691\u2013703.","journal-title":"Haematol"},{"issue":"26","key":"2060_CR19","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1182\/blood-2018-05-844928","volume":"132","author":"W Sun","year":"2018","unstructured":"Sun W, Wu Z, Lin Z, et al. Macrophage TNF-\u03b1 licenses donor T cells in murine bone marrow failure and can be implicated in human aplastic anemia. Blood. 2018;132(26):2730\u201343.","journal-title":"Blood"},{"key":"2060_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00330","volume":"7","author":"JN Smith","year":"2016","unstructured":"Smith JN, Kanwar VS, MacNamara KC. Hematopoietic stem cell regulation by type I and II interferons in the pathogenesis of acquired aplastic anemia. Front Immunol. 2016;7:330.","journal-title":"Front Immunol"},{"issue":"1","key":"2060_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/sj.thj.6200340","volume":"5","author":"JP Welsh","year":"2004","unstructured":"Welsh JP, Rutherford TR, Flynn J, et al. In vitro effects of interferon-gamma and tumor necrosis factor-alpha on CD34+ bone marrow progenitor cells from aplastic anemia patients and normal donors. Hematol J. 2004;5(1):39\u201346.","journal-title":"Hematol J"},{"key":"2060_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02061","volume":"9","author":"AJ Lee","year":"2018","unstructured":"Lee AJ, Ashkar AA. The dual nature of type I and type II interferons. Front Immunol. 2018;9:2061.","journal-title":"Front Immunol"},{"issue":"2","key":"2060_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1084\/jem.20131043","volume":"211","author":"EM Pietras","year":"2014","unstructured":"Pietras EM, Lakshminarasimhan R, Techner JM, et al. Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons. J Exp Med. 2014;211(2):245\u201362.","journal-title":"J Exp Med"},{"issue":"13","key":"2060_CR24","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1182\/blood-2005-05-2096","volume":"106","author":"K Bijangi-Vishehsaraei","year":"2005","unstructured":"Bijangi-Vishehsaraei K, Saadatzadeh MR, Werne A, et al. Enhanced TNF-alpha-induced apoptosis in Fanconi anemia type C-deficient cells is dependent on apoptosis signal-regulating kinase 1. Blood. 2005;106(13):4124\u201330.","journal-title":"Blood"},{"issue":"9","key":"2060_CR25","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.4049\/jimmunol.1003438","volume":"186","author":"BL Esplin","year":"2011","unstructured":"Esplin BL, Shimazu T, Welner RS, et al. Chronic exposure to a TLR ligand injures hematopoietic stem cells. J Immunol. 2011;186(9):5367\u201375.","journal-title":"J Immunol"},{"issue":"6","key":"2060_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.45","volume":"6","author":"AC Herman","year":"2016","unstructured":"Herman AC, Monlish DA, Romine MP, et al. Systemic TLR2 agonist exposure regulates hematopoietic stem cells via cell-autonomous and cell-non-autonomous mechanisms. Blood Cancer J. 2016;6(6):e437.","journal-title":"Blood Cancer J"},{"issue":"21","key":"2060_CR27","doi-asserted-by":"publisher","first-page":"9902","DOI":"10.1073\/pnas.88.21.9902","volume":"88","author":"S Heimfeld","year":"1991","unstructured":"Heimfeld S, Hudak S, Weissman I, et al. The in vitro response of phenotypically defined mouse stem cells and myeloerythroid progenitors to single or multiple growth factors. Proc Natl Acad Sci U S A. 1991;88(21):9902\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2060_CR28","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41577-018-0066-7","volume":"18","author":"SA Jones","year":"2018","unstructured":"Jones SA, Jenkins BJ. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer. Nat Rev Immunol. 2018;18(12):773\u201389.","journal-title":"Nat Rev Immunol"},{"issue":"Pt 9","key":"2060_CR29","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1242\/jcs.003152","volume":"120","author":"X Zhang","year":"2007","unstructured":"Zhang X, Sejas DP, Qiu Y, et al. Inflammatory ROS promote and cooperate with the Fanconi anemia mutation for hematopoietic senescence. J Cell Sci. 2007;120(Pt 9):1572\u201383.","journal-title":"J Cell Sci"},{"key":"2060_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.951937","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Erlacher M, Fernandez-Orth J. The role of inflammation in hematopoiesis and bone marrow failure: what can we learn from mouse models? Front Immunol. 2022;13:951937.","journal-title":"Front Immunol"},{"issue":"9","key":"2060_CR31","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.7150\/thno.71086","volume":"12","author":"Z Rao","year":"2022","unstructured":"Rao Z, Zhu Y, Yang P, et al. Pyroptosis in inflammatory diseases and cancer. Theranostics. 2022;12(9):4310\u201329.","journal-title":"Theranostics"},{"issue":"1","key":"2060_CR32","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13046-021-02065-8","volume":"40","author":"R Loveless","year":"2021","unstructured":"Loveless R, Bloomquist R, Teng Y. Pyroptosis at the forefront of anticancer immunity. J Exp Clin Cancer Res. 2021;40(1):264.","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"2060_CR33","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1016\/j.stemcr.2021.10.011","volume":"16","author":"JE Howard","year":"2021","unstructured":"Howard JE, Smith JNP, Fredman G, et al. IL-18R-mediated HSC quiescence and MLKL-dependent cell death limit hematopoiesis during infection-induced shock. Stem Cell Reports. 2021;16(12):2887\u201399.","journal-title":"Stem Cell Reports"},{"issue":"8","key":"2060_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007234","volume":"14","author":"JNP Smith","year":"2018","unstructured":"Smith JNP, Zhang Y, Li JJ, et al. Type I IFNs drive hematopoietic stem and progenitor cell collapse via impaired proliferation and increased RIPK1-dependent cell death during shock-like ehrlichial infection. PLoS Pathog. 2018;14(8):e1007234.","journal-title":"PLoS Pathog"},{"key":"2060_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01499","volume":"11","author":"AN Seyfried","year":"2020","unstructured":"Seyfried AN, Maloney JM, MacNamara KC. Macrophages orchestrate hematopoietic programs and regulate HSC function during inflammatory stress. Front Immunol. 2020;11:1499.","journal-title":"Front Immunol"},{"issue":"10","key":"2060_CR36","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/ni.2705","volume":"14","author":"LC Davies","year":"2013","unstructured":"Davies LC, Jenkins SJ, Allen JE, et al. Tissue-resident macrophages. Nat Immunol. 2013;14(10):986\u201395.","journal-title":"Nat Immunol"},{"issue":"10","key":"2060_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102369","volume":"18","author":"P Di Benedetto","year":"2019","unstructured":"Di Benedetto P, Ruscitti P, Vadasz Z, et al. Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases. Autoimmun Rev. 2019;18(10):102369.","journal-title":"Autoimmun Rev"},{"issue":"12","key":"2060_CR38","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1002\/cbin.11689","volume":"45","author":"MR Javan","year":"2021","unstructured":"Javan MR, Saki N, Moghimian-Boroujeni B. Aplastic anemia, cellular and molecular aspects. Cell Biol Int. 2021;45(12):2395\u2013402.","journal-title":"Cell Biol Int"},{"issue":"11","key":"2060_CR39","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1182\/blood.V84.11.3685.bloodjournal84113685","volume":"84","author":"LA Holmberg","year":"1994","unstructured":"Holmberg LA, Seidel K, Leisenring W, et al. Aplastic anemia: analysis of stromal cell function in long-term marrow cultures. Blood. 1994;84(11):3685\u201390.","journal-title":"Blood"},{"issue":"4","key":"2060_CR40","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1182\/blood-2002-01-0035","volume":"100","author":"E Sloand","year":"2002","unstructured":"Sloand E, Kim S, Maciejewski JP, et al. Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia. Blood. 2002;100(4):1185\u201391.","journal-title":"Blood"},{"issue":"9","key":"2060_CR41","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1007\/s00277-005-1022-8","volume":"84","author":"S Dubey","year":"2005","unstructured":"Dubey S, Shukla P, Nityanand S. Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia. Ann Hematol. 2005;84(9):572\u20137.","journal-title":"Ann Hematol"},{"issue":"9","key":"2060_CR42","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1056\/NEJMoa1110556","volume":"366","author":"C Harrison","year":"2012","unstructured":"Harrison C, Kiladjian JJ, Al-Ali HK, et al. JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis. N Engl J Med. 2012;366(9):787\u201398.","journal-title":"N Engl J Med"},{"issue":"3","key":"2060_CR43","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1056\/NEJMoa2033122","volume":"385","author":"R Zeiser","year":"2021","unstructured":"Zeiser R, Polverelli N, Ram R, et al. Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease. N Engl J Med. 2021;385(3):228\u201338.","journal-title":"N Engl J Med"},{"issue":"1","key":"2060_CR44","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41408-023-00875-x","volume":"13","author":"C Courdy","year":"2023","unstructured":"Courdy C, Platteeuw L, Ducau C, et al. Targeting PP2A-dependent autophagy enhances sensitivity to ruxolitinib in JAK2(V617F) myeloproliferative neoplasms. Blood Cancer J. 2023;13(1):106.","journal-title":"Blood Cancer J"},{"issue":"3","key":"2060_CR45","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s10637-019-00812-5","volume":"38","author":"JA Machado-Neto","year":"2020","unstructured":"Machado-Neto JA, Coelho-Silva JL, Santos FPS, et al. Autophagy inhibition potentiates ruxolitinib-induced apoptosis in JAK2(V617F) cells. Invest New Drugs. 2020;38(3):733\u201345.","journal-title":"Invest New Drugs"},{"issue":"42","key":"2060_CR46","doi-asserted-by":"publisher","first-page":"26834","DOI":"10.18632\/oncotarget.25515","volume":"9","author":"S Ishida","year":"2018","unstructured":"Ishida S, Akiyama H, Umezawa Y, et al. Mechanisms for mTORC1 activation and synergistic induction of apoptosis by ruxolitinib and BH3 mimetics or autophagy inhibitors in JAK2-V617F-expressing leukemic cells including newly established PVTL-2. Oncotarget. 2018;9(42):26834\u201351.","journal-title":"Oncotarget"},{"issue":"18","key":"2060_CR47","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.2174\/1871520620666200218105159","volume":"20","author":"A Kusoglu","year":"2020","unstructured":"Kusoglu A, Bagca BG, Ay NPO, et al. Ruxolitinib regulates the autophagy machinery in multiple myeloma cells. Anticancer Agents Med Chem. 2020;20(18):2316\u201323.","journal-title":"Anticancer Agents Med Chem"},{"issue":"2","key":"2060_CR48","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s13277-015-3947-4","volume":"37","author":"BG Bagca","year":"2016","unstructured":"Bagca BG, Ozalp O, Kurt CC, et al. Ruxolitinib induces autophagy in chronic myeloid leukemia cells. Tumour Biol. 2016;37(2):1573\u20139.","journal-title":"Tumour Biol"},{"issue":"7","key":"2060_CR49","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41419-022-05053-8","volume":"13","author":"H Guo","year":"2022","unstructured":"Guo H, Liang S, Wang Y, et al. Cytochrome B5 type A alleviates HCC metastasis via regulating STOML2 related autophagy and promoting sensitivity to ruxolitinib. Cell Death Dis. 2022;13(7):623.","journal-title":"Cell Death Dis"},{"issue":"9","key":"2060_CR50","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa1110557","volume":"366","author":"S Verstovsek","year":"2012","unstructured":"Verstovsek S, Mesa RA, Gotlib J, et al. A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis. N Engl J Med. 2012;366(9):799\u2013807.","journal-title":"N Engl J Med"},{"issue":"19","key":"2060_CR51","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1056\/NEJMoa1917635","volume":"382","author":"R Zeiser","year":"2020","unstructured":"Zeiser R, von Bubnoff N, Butler J, et al. Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease. N Engl J Med. 2020;382(19):1800\u201310.","journal-title":"N Engl J Med"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02060-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02060-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02060-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T03:03:38Z","timestamp":1770692618000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02060-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2060"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02060-3","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"27 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All mouse experiments were reviewed and approved by the Ethics Committee of Tianjin Medical University General Hospital (IRB2025-DW-67).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"137"}}